| Ticker Symbol: | SQNM |
|---|---|
| Exchange: | NASD |
| Contact Info: | 3595 John Hopkins Court San Diego CA 92121 858 202-9000 |
| CEO/President: | Harry Stylli Ph.D. |
| Industry: | Medical - Biomedical / Standard Industry Code: 8731 |
| Description: | Sequenom Inc. is in the field of industrial genomics. Industrial genomics is the large scale commercial use of the knowledge of DNA variations for improving health, agriculture and livestock. These variations are the differences between individuals, including disease predispositions and variations in drug responses. Single nucleotide polymorphisms are the most common variations. The company has developed the MassArray system, an accurate, cost-effective technology that is capable of high throughput single nucleotide polymorphism analysis at high speeds. |
| Shares Outstanding: | 50,260 (000) | Market Value: | 904,740 ($000) |
|---|---|---|---|
| Percentage of Inst.Shareholders: | 70.18% | Number of Inst.Shareholders: | 3.60% |
| Last Quarter Sales: | 12.85 ($Mil.) | Last Quarter Net Income: | -9.74 ($Mil.) |
| Last Quarter EPS: | -0.21 | P/E Ratio: | 0 |
| Most Recent Earnings: | -0.21 on 07/30/08 | Earnings Per Share: | -0.70 |
| Most Recent Split: | 1-3 on 06/02/06 | Annual Dividend Rate: | 0 |
| Most Recent Dividend: | Annual Dividend Yield: | 0% |


| AMGEN | -15.10 | 48.58 | |
| GILEAD SCIENCES | -26.60 | 37.47 | |
| GENENTECH INC | -9.90 | 73.00 | |
| CELGENE CP | -26.70 | 54.52 | |
| BIOGEN IDEC INC | -34.90 | 42.78 |
